Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptor

Journal of Experimental Medicine

Volumn 187, Issue 10, 1998, Pages 1699-1709

  Chau, Luan A ^a   Bluestone, Jeffrey A ^c   Madrenas, Joaquín ^a,b,d  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF CHICAGO   (United States)

^d Kidney Foundation of   (Canada)

Author keywords

Mitogen activated protein kinases; P120 GAP; Partial agonist; Signal transduction; T cell receptor

Indexed keywords

CD4 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD4; CLONE CELLS; LIGANDS; MICE; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 0000110483     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.10.1699     Document Type: Article

References (82)

1. Wange, R.L., and L.E. Samelson. 1996. Complex complexes: signaling at the TCR. Immunity. 5:197-205.
2. Noh, D.Y., S.H. Shin, and S.G. Rhee. 1995. Phosphoinositide-specific phospholipase C and mitogenic signaling. Biochim. Biophys. Acta. 1242:99-113.
3. Izquierdo, M., S.J. Leevers, C.J. Marshall, and D. Cantrell. 1993. p21ras couples the T cell antigen receptor to extracellular signal-regulated kinase 2 in T lymphocytes. J. Exp. Med. 178:1199-1208.
4. Weiss, A., and D.R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell. 76:263-274.
5. Rudd, C.E., O. Janssen, Y.-C. Cai, A.J. da Silva, M. Raab, and K.V.S. Prasad. 1994. Two-step TCR/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol. Today. 15:225-234.
6. Franklin, R.A., A. Tordai, H. Patel, A.M. Gardner, G.L. Johnson, and E.W. Gelfand. 1994. Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/ MAPK cascade in human T lymphocytes. J. Clin. Invest. 93:2134-2140.
7. Sette, A., J. Alexander, J. Ruppert, K. Snoke, A. Franco, G. Ishioka, and H.M. Grey. 1994. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12:413-431.
8. Jameson, S.C., and M.J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity. 2:1-11.
9. De Magistris, M., J. Alexander, M. Coggeshall, A. Altman, F.C. Gaeta, H.M. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 68:625-634.
10. Racioppi, L., F. Ronchese, L.A. Matis, and R.N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1047-1060.
11. Kersh, G.J., and P.M. Allen. 1996. Essential flexibility in the T-cell recognition of antigen. Nature. 380:495-498.
12. Madrenas, J., and R.N. Germain. 1996. Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T cell activation. Semin. Immunol. 8:83-101.
13. Sloan-Lancaster, J., A.S. Shaw, J.B. Rothbard, and P.M. Allen. 1994. Partial T cell signalling: altered phospho-ζ and lack of Zap70 recruitment in APL-induced T cell anergy. Cell. 79:913-922.
14. Madrenas, J., R.L. Wange, J.L. Wang, N.A. Isakov, L.E. Samelson, and R.N. Germain. 1995. ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science. 267:515-518.
15. Beeson, C., J. Rabinowitz, K. Tate, I. Gütgemann, Y. Chien, P.P. Jones, M.M. Davis, and H.M. McConnell. 1996. Early biochemical signals arise from low affinity TCR-ligand reactions at the cell-cell interface. J. Exp. Med. 184:777-782.
16. Rabmowitz, J.D., C. Beeson, C. Wülfing, K. Tate, P.M. Allen, M.M. Davis, and H.M. McConnell. 1996. Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity. 5:125-135.
17. Sloan-Lancaster, J., T.H. Steinberg, and P.M. Allen. 1996. Selective activation of the calcium signaling pathway by altered peptide ligands. J. Exp. Med. 184:1525-1530.
18. Wülfing, C., J.D. Rabinowitz, C. Beeson, M.D. Sjaastad, H.M. McConnell, and M.M. Davis. 1997. Kinetics and extent of T cell activation as measured with the calcium signal. J. Exp. Med. 185:1815-1825.
19. Valitutti, S., S. Muller, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature. 375:148-151.
20. Sloan-Lancaster, J., and P.M. Allen. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1-27.
21. Boyer, C., N. Auphan, F. Luton, J.M. Malburet, M. Barad, J.P. Bizozzero, H. Reggio, and A.M. Schmitt-Verhulst. 1991. T cell receptor/CD3 complex internalization following activation of a cytolytic T cell clone: evidence for a protein kinase C-independent staurosporine-sensitive step. Eur. J. Immunol. 21:1623-1634.
22. Sleckman, B.P., J. Shin, V.E. Igras, T.L. Collins, J.L. Srrominger, and S.J. Burakoff. 1992. Disruption of the CD-4-p56lck complex is required for rapid internalization of CD4. Proc. Natl. Acad. Sci. USA. 89:7566-7570.
23. Luton, F., M. Buferne, J. Davoust, A.M. Schmitt-Verhulst, and C. Boyer. 1994. Evidence for protein tyrosine kinase involvement in ligand-induced TCR/CD3 internalization and surface redistribution. J. Immunol. 153:63-72.
24. Seger, R., and E.G. Krebs. 1995. The MAPK signaling cascade. FASEB J. 9:726-735.
25. Matis, L.A., L.H. Glimcher, W.E. Paul, and R.H. Schwartz. 1983. Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc. Natl. Acad. Sci. USA. 80:6019-6023.
26. Ronchese, F., R.H. Schwartz, and R.N. Germain. 1987. Functionally distinct subsites on a class II major histocompatibility complex molecule. Nature. 329:254-256.
27. König, R., X. Shen, and R.N. Germain. 1995. Involvement of both major histocompatibility complex class II α and β chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182:779-787.
28. Kostelny, S.A., M.S. Cole, and J.Y. Tso. 1992. Formation of a bispecific antibody by the use of leucine zippers. J. Immunol. 148:1547-1553.
29. Weiner, G.J., S.A. Kostelny, J.R. Hillstrom, M.S. Cole, B.K. Link, S.L. Wang, and J.Y. Tso. 1994. The role of T cell activation in anti-CD3 x antitumor bispecific antibody therapy. J. Immunol. 152:2385-2392.
30. Weiner, G.J., and G.C. De Gast. 1995. Bispecific monoclonal antibody therapy of B-cell malignancy. Leuk. Lymphoma. 16:199-207.
31. Moreno, M.B., J.A. Titus, M.S. Cole, J.Y. Tso, N. Le, C.H. Paik, T. Bakacs, C.M. Zacharchuk, D.M. Segal, and J.R. Wunderlich. 1995. Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivo. Cancer Immunol. Immunother. 40:182-190.
32. Alegre, M.L., J.Y. Tso, H.A. Sattar, J. Smith, F. Desalle, M. Cole, and J.A. Bluestone. 1995. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogemcity. J. Immunol. 155:1544-1555.
33. Madrenas, J., L.A. Chau, J. Smith, J.A. Bluestone, and R.N. Germain. 1997. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185:219-230.
34. Smith, J.A., J.Y. Tso, M.R. Clark, M.S. Cole, and J.A. Bluestone. 1997. Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy. J. Exp. Med. 185:1413-1422.
35. Lee, J.E., M.B. Cossoy, L.A. Chau, B. Singh, and J. Madrenas. 1997. Lck inactivation and loss of TCR-mediated signalling upon persistent engagement with complexes of peptide: MHC molecules. J. Immunol. 159:61-69.
36. Iwashima, M., B.A. Irving, N.S.C. van Oers, A.C. Chan, and A. Weiss. 1994. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science. 263:1136-1139.
37. Diez-Orejas, R., S. Ballester, M.J. Feito, G. Ojeda, G. Criado, M. Ronda, P. Portoles, and J.M. Rojo. 1994. Genetic and immunochemical evidence for CD4-dependent association of p56lck with the alpha beta T-cell receptor (TCR): regulation ot TCR-induced activation. EMBO (Eur. Mol. Biol. Organ.) J. 13:90-99.
38. Valitutti, S., and A. Lanzavecchia. 1997. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol. Today. 18:299-304.
39. Cantrell, D.A., A.A. Davies, and M.J. Crumpton. 1985. Activators of protein kinase C down-regulate and phosphorylate the T3/T-cell antigen receptor complex of human T lymphocytes. Proc. Natl. Acad. Sci. USA. 82:8158-8162.
40. Dietrich, J., X. Hou, A.M. Wegener, and C. Geisler. 1994. CD3 gamma contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor. EMBO (Eur. Mol. Biol. Organ.) J. 13:2156-2166.
41. Dietrich, J., X. Hou, A.M. Wegener, L.O. Pedersen, N. Odum, and C. Geisler. 1996. Molecular characterization of the di-leucine-based internalization motif of the T cell receptor. J. Biol. Chem. 271:11441-11448.
42. Dietrich, J., J. Kastrup, B.L. Nielsen, N. Odum, and C. Geisler. 1997. Regulation and function of the CD3 gamma DxxxLL motif: a binding site for adaptor protein-1 and adaptor protem-2 in vitro. J. Cell Biol. 138:271-281.
43. Luton, F., V. Legendre, J.P. Gorvel, A.M. Schmitt-Verhulst, and C. Boyer. 1997. Tyrosine and serine protein kinase activities associated with ligand-induced internalized TCR/CD3 complexes. J. Immunol. 158:3140-3147.
44. Ericsson, P.-O., P.L. Orchansky, D.A. Carlow, and H.-S. Teh. 1996. Differential activation of phospholipase C-γ1 and mitogen-activated protein kinase in naive and antigen-primed CD4 T cells by the peptide/MHC ligand. J. Immunol. 156:2045-2053.
45. Marshall, M.S. 1995. Ras target proteins in eukaryotic cells. FASEB J. 9:1311-1318.
46. Marshall, C.J. 1996. Ras effectors. Curr. Opin. Cell Biol. 8:197-204.
47. Katz, M.E., and F. McCormick. 1997. Signal transduction from multiple Ras effectors. Cnrr. Opin. Genet. Dev. 7:75-79.
48. Tocque, B., I. Delumeau, F. Parker, F. Maurier, M.C. Multon, and F. Schweighoffer. 1997. Ras-GTPase activating protein (GAP): a putative effector for Ras. Cell. Signalling. 9:153-158.
49. Ellis, C., X.Q. Liu, D. Anderson, N. Abraham, A. Veillette, and T. Pawson. 1991. Tyrosine phosphorylation of GAP and GAP-associated proteins in lymphoid and fibroblast cells expressing lck. Oncogene. 6:895-901.
50. Amrein, K.E., N. Flint, B. Panholzer, and P. Burn. 1992. Ras GTPase-activating protein: a substrate and a potential binding protein of the protein-tyrosine kinase p56lck. Proc. Natl. Acad. Sci. USA. 89:3343-3346.
51. Veillette, A., M.A. Bookman, E.M. Horak, and J.B. Bolen. 1988. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell. 55:301-308.
52. Chan, A.C., M. Iwashima, C.W. Turck, and A. Weiss. 1992. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell. 71:649-662.
53. Wange, R.L., A.N. Kong, and L.E. Samelson. 1992. A tyrosine-phosphorylated 70-kDa protein binds a photoaffinity analogue of ATP and associates with both the zeta chain and CD3 components of the activated T cell antigen receptor. J. Biol. Chem. 267:11685-11688.
54. Neumeister, E.N., Y. Zgu, S. Richard, C. Terhorst, A.C. Chan, and A.S. Shaw. 1995. Binding of ZAP-70 to phosphorylated T-cell receptor ζ and η enhances its autophosphorylation and generates specific binding sites for SH2 domain-containing proteins. Mol. Cell. Biol. 15:3171-3178.
55. Rickles, R.J., M.C. Botfield, X.M. Zhou, P.A. Henry, J.S. Brugge, and M.J. Zoller. 1995. Phage display selection of ligand residues important for Src homology 3 domain binding specificity. Proc. Natl. Acad. Sci. USA. 92:10909-10913.
56. Parker, F., F. Maurier, I. Delumeau, M. Duchesne, D. Faucher, L. Debussche, A. Dugue, F. Schweighoffer, and B. Tocque. 1996. A Ras-GTPase-activating protein SH3-domain-binding protein. Mol. Cell. Biol. 16:2561-2569.
57. August, A., and B. Dupont. 1996. Association between mitogen-activated protein kinase and the ζ chain of the T cell receptor (TcR) with the SH2,3 domain of p56lck. Differential regulation by TcR cross-linking. J. Biol. Chem. 271:10054-10059.
58. Hubert, P., F. Debre, L. Boumsell, and G. Bismuth. 1993. Tyrosine phosphorylation and association with phospholipase C gamma-1 of the GAP-associated 62-kD protein after CD2 stimulation of Jurkat T cell. J. Exp. Med. 178:1587-1596.
59. Jabado, N., A. Pallier, F. Le Deist, F. Bernard, A. Fischer, and C. Hivroz. 1997. CD4 ligands inhibit the formation of multifunctional transduction complexes involved in T cell activation. J. Immunol. 158:94-103.
60. Nel, A.E., S. Pollack, G. Landreth, J.A. Ledbetter, L. Hultin, K. Williams, R. Katz, and B. Akerley. 1990. CD-3-mediated activation of the MAP-2 kinase can be modified by ligation of the CD4 receptor. Evidence for tyrosine phosphorylation during activation of this kinase. J. Immunol. 145:971-979.
61. Hampl, J., Y. Chien, and M.M. Davis. 1997. CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity. 7:379-385.
62. Alam, S.M., P.J. Travers, J.L. Wung, W. Nasholds, S. Redpath, S.C. Jameson, and N.R.J. Gascoigne. 1996. T-cell-receptor affinity and thymocyte positive selection. Nature. 381:616-620.
63. Lyons, D.S., S.A. Lieberman, J. Hampl, J.J. Boniface, Y. Chien, L.J. Berg, and M.M. Davis. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity. 5:51-59.
64. Janeway, C.J., and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell. 76:275-285.
65. Racioppi, L., G. Matarese, U. D'Oro, M. De Pascale, A.M. Masci, S. Fontana, and S. Zappacosta. 1996. The role of CD4-lck in T-cell receptor antagonism: evidence for negative signaling. Proc. Natl. Acad. Sci. USA. 93:10360-10365.
66. Reich, Z., J.J. Boniface, D.S. Lyons, N. Borochov, E.J. Wachtel, and M.M. Davis. 1997. Ligand-specific oligomerization of T-cell receptor molecules. Nature. 387:617-620.
67. Ettehadieh, E., J.S. Sanghera, S.L. Pelech, D. Hess-Bienz, J. Watts, N. Shastri, and R. Aebersold. 1992. Tyrosyl phosphorylation and activation of MAP kjnases by p56lck. Science. 255:853-855.
68. Gupta, S., A. Weiss, G. Kumar, S. Wang, and A. Nel. 1994. The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. Evidence for the existence of a second protein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant. J. Biol. Chem. 269:17349-17357.
69. Sozeri, O., K. Vollmer, M. Liyanage, D. Frith, G. Kour, G.E.D. Mark, and S. Stabel. 1992. Activation of the c-Raf protein kinase by protein kinase C phosphorylation. Oncogene. 7:2259-2262.
70. Kolch, W., G. Heidecker, G. Kochs, R. Hummel, H. Vahidi, H. Mischak, G. Finkenzeller, D. Marme, and U.R. Rapp. 1993. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature. 364:249-252.
71. Siegel, J.N., C.H. June, H. Yamada, U.R. Rapp, and L.E. Samelson. 1993. Rapid activation of C-Raf-1 after stimulation of the T-cell receptor or the muscarinic receptor type 1 in resting T cells. J. Immunol. 151:4116-4127.
72. Ueda, Y., S. Hirai, S. Osada, A. Suzuki, K. Mizuno, and S. Ohno. 1996. Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J. Biol. Chem. 271:23512-23519.
73. August, A., and B. Dupont. 1995. Activation of extracellular signal-regulated protein kinase (ERK/MAP kinase) following CD28 cross-linking: activation in cells lacking p56lck. Tissue Antigens. 46:155-162.
74. Molina, T.J., K. Kishihara, D.P. Siderovski, W. Ewijk van, A. Narendran, E. Timms, A. Wakeham, C.J. Paige, K.U. Hartmann, A. Veillette, et al. 1992. Profound block in thymocyte development in mice lacking p56lck. Nature. 357:161-164.
75. Alberola-Ila, J., K.A. Forbush, R. Seger, E.G. Krebs, and R.M. Perlmutter. 1995. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature. 373:620-623.
76. Alberola-Ila, J., K.A. Hogquist, K.A. Swan, M.J. Bevan, and R.M. Perlmutter. 1996. Positive and negative selection invoke distinct signaling pathways. J. Exp. Med. 184:9-18.
77. Crompton, T., K.C. Gilmour, and M.J. Owen. 1996. The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte. Cell. 86:243-251.
78. van Oers, N.S.C., N. Killeen, and A. Weiss. 1996. Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes. J. Exp. Med. 183:1053-1062.
79. Ramos-Morales, F., B.J. Druker, and S. Fischer. 1994. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes. Oncogene. 9:1917-1923.
80. Gulbins, E., K.M. Coggeshall, C. Langlet, G. Baier, N. Bonnefoy-Berard, P. Burn, A. Wittinghofer, S. Katzav, and A. Altman. 1994. Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein. Mol. Cell. Biol. 14:906-913.
81. Stokoe, D., S.G. Macdonald, K. Cadwallader, M. Symons, and J.F. Hancock. 1994. Activation of Raf as a result of recruitment to the plasma membrane. Science. 264:1463-1467.
82. + T cells. J. Exp. Med. 186:757-766.